You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 4, April 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Presidential Address
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Surgery
 •Surgical Oncology
 •Genetics
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Tradition, Teamwork, and Tailored Treatment

Surgical Oncology in the Genomic Era

Gregory T. Wolf, MD

Arch Otolaryngol Head Neck Surg. 2009;135(4):337-341.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The next decade will be one of the most exciting, challenging, and, perhaps, unsettling eras in head and neck surgical oncology. We can expect surgical dogma and traditional oncologic principles to be challenged in every aspect. These challenges will be raised by experienced colleagues who have observed the evolution of our understanding of tumor behavior and the limitations of conventional surgery, radiotherapy, and chemotherapy. New questions will be raised because of increasing knowledge of the basic biological characteristics of carcinogenesis, cellular proliferation, and immune homeostasis. How should we prepare ourselves and the next generation of surgical oncologists for these challenges? I believe that we are at a critical crossroads in head and neck oncology between a well-worn highway of surgical technique and a newer roadway of tumor biology and molecular medicine. The obvious main roadway will lead to superb technical advancements in areas such as free . . . [Full Text of this Article]

HYPOTHESIS

THE CHALLENGE TO SURGEONS

PARADIGM 1: TREATMENT SELECTION

PARADIGM 2: BIOLOGICAL STAGING

PARADIGM 3: MOLECULAR RISK ASSESSMENT

A NEW TRADITION AND TEAM

AUTHOR INFORMATION

Author Affiliation: Department of Otolaryngology, University of Michigan, Ann Arbor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.